Can seladelpar improve liver function in primary biliary cholangitis?
Seladelpar is a selective PPAR-delta agonist recently approved as a second-line therapy for primary biliary cholangitis (PBC). Clinical trials show it improves key markers of liver function, such as alkaline phosphatase (ALP) and bilirubin, which are used to track disease progression. This answer focuses on what the research says about seladelpar's effects on liver function, not just symptom relief.
What the research says
In the phase 3 RESPONSE study, patients with PBC and compensated cirrhosis who took seladelpar 10 mg daily for 12 months were more likely to reach a composite endpoint of improved liver function (ALP <1.67 times the upper limit of normal, ALP decrease ≥15%, and total bilirubin ≤ upper limit of normal) compared to placebo (38.9% vs. 22.2%). Seladelpar also reduced ALP by an average of 37.1% from baseline, versus 10.1% with placebo 5. These benefits were maintained in the open-label ASSURE study, where patients continued seladelpar for up to 2 years 5. A meta-analysis of five randomized trials (including seladelpar) confirmed that PPAR agonists significantly improve pruritus and quality of life, but also noted biochemical improvements 2. Seladelpar's effects on liver function are thought to stem from its action on bile acid metabolism and inflammation 68. Importantly, seladelpar does not appear to worsen hepatic steatosis (fatty liver), which is common in PBC patients 3. While seladelpar improves liver tests, it is not a cure; some patients may still progress to cirrhosis or need a liver transplant 46.
What to ask your doctor
- Is seladelpar an option for me given my current liver function and PBC stage?
- How will my alkaline phosphatase and bilirubin levels be monitored while on seladelpar?
- What are the potential side effects of seladelpar, especially regarding pruritus or liver enzymes?
- Should I continue taking ursodeoxycholic acid (UDCA) along with seladelpar?
- How does seladelpar compare to other second-line therapies like obeticholic acid or elafibranor for my situation?
This question is drawn from common patient questions about Gastroenterology and answered using cited medical research. We do not provide individualized advice.